Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24910991)

1.

Effect of broccoli sprouts on nasal response to live attenuated influenza virus in smokers: a randomized, double-blind study.

Noah TL, Zhang H, Zhou H, Glista-Baker E, Müller L, Bauer RN, Meyer M, Murphy PC, Jones S, Letang B, Robinette C, Jaspers I.

PLoS One. 2014 Jun 9;9(6):e98671. doi: 10.1371/journal.pone.0098671. eCollection 2014.

2.

Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus.

Horvath KM, Herbst M, Zhou H, Zhang H, Noah TL, Jaspers I.

Respir Res. 2011 Aug 4;12:102. doi: 10.1186/1465-9921-12-102.

3.

Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus.

Noah TL, Zhou H, Monaco J, Horvath K, Herbst M, Jaspers I.

Environ Health Perspect. 2011 Jan;119(1):78-83. doi: 10.1289/ehp.1002258. Epub 2010 Oct 4.

4.

Localized mucosal response to intranasal live attenuated influenza vaccine in adults.

Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.

J Infect Dis. 2013 Jan 1;207(1):115-24. doi: 10.1093/infdis/jis641. Epub 2012 Oct 19.

5.

Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.

Davidson LE, Fiorino AM, Snydman DR, Hibberd PL.

Eur J Clin Nutr. 2011 Apr;65(4):501-7. doi: 10.1038/ejcn.2010.289. Epub 2011 Feb 2.

6.

Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.

Riedl MA, Saxon A, Diaz-Sanchez D.

Clin Immunol. 2009 Mar;130(3):244-51. doi: 10.1016/j.clim.2008.10.007. Epub 2008 Nov 22.

7.

Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Fischer WA 2nd, Chason KD, Brighton M, Jaspers I.

Vaccine. 2014 Mar 26;32(15):1761-7. doi: 10.1016/j.vaccine.2013.12.069. Epub 2014 Jan 30.

8.

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T.

J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428.

9.

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.

Vaccine. 2011 Nov 21;29(50):9391-7. doi: 10.1016/j.vaccine.2011.09.109. Epub 2011 Oct 6.

PMID:
21983154
10.

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.

Heldens J, Hulskotte E, Voeten T, Breedveld B, Verweij P, van Duijnhoven W, Rudenko L, van Damme P, van den Bosch H.

Vaccine. 2014 Sep 3;32(39):5118-24. doi: 10.1016/j.vaccine.2014.05.030. Epub 2014 May 23.

PMID:
24858566
11.

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O.

PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014.

12.

Diesel exhaust exposure and nasal response to attenuated influenza in normal and allergic volunteers.

Noah TL, Zhou H, Zhang H, Horvath K, Robinette C, Kesic M, Meyer M, Diaz-Sanchez D, Jaspers I.

Am J Respir Crit Care Med. 2012 Jan 15;185(2):179-85. doi: 10.1164/rccm.201103-0465OC. Epub 2011 Oct 27.

13.

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J.

JAMA. 1999 Jul 14;282(2):137-44.

PMID:
10411194
14.

T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Li J, Arévalo MT, Chen Y, Chen S, Zeng M.

Int J Infect Dis. 2014 Oct;27:37-43. doi: 10.1016/j.ijid.2014.05.016. Epub 2014 Aug 27.

15.

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.

Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD; D153-P504 LAIV Study Group.

Pediatr Infect Dis J. 2009 May;28(5):365-71. doi: 10.1097/INF.0b013e31819219b8.

PMID:
19395948
16.

Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial.

Klick B, Durrani S, Chan KH, Ip DK, Chou ES, Kwok HK, Ng S, Chiu SS, Peiris JS, Leung GM, Cowling BJ.

Vaccine. 2013 Apr 8;31(15):1937-43. doi: 10.1016/j.vaccine.2013.02.017. Epub 2013 Feb 19.

PMID:
23434387
17.

Live attenuated influenza virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers.

Horvath KM, Brighton LE, Herbst M, Noah TL, Jaspers I.

Clin Immunol. 2012 Mar;142(3):232-6. doi: 10.1016/j.clim.2011.12.013. Epub 2012 Jan 6.

18.

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older.

De Villiers PJ, Steele AD, Hiemstra LA, Rappaport R, Dunning AJ, Gruber WC, Forrest BD; LAIV Elderly Study Trial Network.

Vaccine. 2009 Dec 10;28(1):228-34. doi: 10.1016/j.vaccine.2009.09.092. Epub 2009 Sep 29.

PMID:
19796721
19.

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.

Mallory RM, Malkin E, Ambrose CS, Bellamy T, Shi L, Yi T, Jones T, Kemble G, Dubovsky F.

PLoS One. 2010 Oct 29;5(10):e13755. doi: 10.1371/journal.pone.0013755.

20.

Live attenuated and inactivated influenza vaccines in children.

Ilyushina NA, Haynes BC, Hoen AG, Khalenkov AM, Housman ML, Brown EP, Ackerman ME, Treanor JJ, Luke CJ, Subbarao K, Wright PF.

J Infect Dis. 2015 Feb 1;211(3):352-60. doi: 10.1093/infdis/jiu458. Epub 2014 Aug 26.

PMID:
25165161
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk